A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques
Ronald R. Cobb, James E. Crowe(Vanderbilt University Medical Center), Manuel Hechenblaickner, Christopher G. Earnhart(United States Department of Defense), Genevieve H. Nonet, Jingyou Yu(First Affiliated Hospital of Guangzhou Medical University), Robert H. Carnahan(Vanderbilt University Medical Center), Brian Hoppe, Doris M. Snow, Kyal Hackett, Milan T. Tomic(Life Services (United States)), Pavlo Gilchuk(AstraZeneca (Japan)), Laura A. VanBlargan(Washington University in St. Louis), James C. Slaughter(Vanderbilt University Medical Center), Mark G. Lewis(Bioqual), Dan H. Barouch(Beth Israel Deaconess Medical Center), Rita E. Chen(Washington University in St. Louis), Abishek Chandrashekar(Beth Israel Deaconess Medical Center), Nicole M. Dorsey(United States Department of Defense), Michael Diamond(Washington University in St. Louis), Joseph P. Nkolola(Beth Israel Deaconess Medical Center), Anthony Cook, Hanné Andersen(Bioqual), Svetlana A. Hopkins(Logistics Management Institute (United States)), Robert V. House(The White House), Laura Collins(University of Iowa)
Cited by 23
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
|New England Journal of Medicine|2020|1.2k